Trial NCT03232307

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0280
Secondary IDs: 2016-0280 NCI-2018-01271 P30CA016672

Last trial update was posted on 2019-08-22

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological BB 1101 Dexamethasone Dexamethasone acetate Ibrutinib Immunoglobulins Lenalidomide Rituximab

MeSH Conditions

Lymphoma Lymphoma, Mantle-Cell

Other Conditions

CCND1 Positive CD20-Positive Neoplastic Cells Present Mantle Cell Lymphoma

Stopping Reasons

Sponsor does not wish to proceed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID